CVI Investments, Inc. 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:30 pm Sale |
2021-12-31 | 13G | Evofem Biosciences, Inc. EVFM |
CVI Investments, Inc. | 5,333 5.800% |
-2,969 (-35.76%) |
Filing |
| 2021-05-28 10:33 am Purchase |
2021-05-18 | 13G | Evofem Biosciences, Inc. EVFM |
CVI Investments, Inc. | 8,303 9.900% |
8,303 (New Position) |
Filing |